These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 32682202)

  • 1. Discovery of tofacitinib derivatives as orally active antitumor agents based on the scaffold hybridization strategy.
    Shi XJ; Wang S; Li XJ; Yuan XH; Cao LJ; Yu B; Liu HM
    Eur J Med Chem; 2020 Oct; 203():112601. PubMed ID: 32682202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumor evaluation of novel phenothiazine derivatives that inhibit migration and tubulin polymerization against gastric cancer MGC-803 cells.
    Liu N; Jin Z; Zhang J; Jin J
    Invest New Drugs; 2019 Feb; 37(1):188-198. PubMed ID: 30345465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug repurposing: Discovery of troxipide analogs as potent antitumor agents.
    Lu N; Huo JL; Wang S; Yuan XH; Liu HM
    Eur J Med Chem; 2020 Sep; 202():112471. PubMed ID: 32619887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis and in vitro biological evaluation of novel [1,2,3]triazolo[4,5-d]pyrimidine derivatives containing a thiosemicarbazide moiety.
    Geng PF; Liu XQ; Zhao TQ; Wang CC; Li ZH; Zhang J; Wei HM; Hu B; Ma LY; Liu HM
    Eur J Med Chem; 2018 Feb; 146():147-156. PubMed ID: 29407946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis and biological evaluation of [1,2,3]triazolo[4,5-d]pyrimidine derivatives possessing a hydrazone moiety as antiproliferative agents.
    Li ZH; Yang DX; Geng PF; Zhang J; Wei HM; Hu B; Guo Q; Zhang XH; Guo WG; Zhao B; Yu B; Ma LY; Liu HM
    Eur J Med Chem; 2016 Nov; 124():967-980. PubMed ID: 27771599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of new [1,2,4] Triazolo[1,5-a]Pyrimidine derivatives that Kill gastric cancer cells via the mitochondria pathway.
    Wang S; Ma XB; Yuan XH; Yu B; Xu YC; Liu HM
    Eur J Med Chem; 2020 Oct; 203():112630. PubMed ID: 32683165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of [1,2,4]triazolo[1,5-a]pyrimidines derivatives as potential anticancer agents.
    Huo JL; Wang S; Yuan XH; Yu B; Zhao W; Liu HM
    Eur J Med Chem; 2021 Feb; 211():113108. PubMed ID: 33385852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, Synthesis and Biological Evaluation of [1,2,4]Triazolo[1,5-
    Yu GX; Hu Y; Zhang WX; Tian XY; Zhang SY; Zhang Y; Yuan S; Song J
    Molecules; 2022 Aug; 27(15):. PubMed ID: 35956943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and synthesis of novel pyrazolo[1,5-a]pyrimidine derivatives bearing nitrogen mustard moiety and evaluation of their antitumor activity in vitro and in vivo.
    Zhao M; Ren H; Chang J; Zhang D; Yang Y; He Y; Qi C; Zhang H
    Eur J Med Chem; 2016 Aug; 119():183-96. PubMed ID: 27162123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis and biological evaluation of novel 2,4-bismorpholinothieno[3,2-d]pyrimidine and 2-morpholinothieno[3,2-d]pyrimidinone derivatives as potent antitumor agents.
    Ye T; Han Y; Wang R; Yan P; Chen S; Hou Y; Zhao Y
    Bioorg Chem; 2020 Jun; 99():103796. PubMed ID: 32283346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel [1,2,3]triazolo[4,5-d]pyrimidine derivatives containing hydrazone fragment as potent and selective anticancer agents.
    Xu C; Zhou W; Dong G; Qiao H; Peng J; Jia P; Li Y; Liu H; Sun K; Zhao W
    Bioorg Chem; 2020 Dec; 105():104424. PubMed ID: 33161253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and synthesis of novel 1,2,3-triazole-pyrimidine hybrids as potential anticancer agents.
    Ma LY; Pang LP; Wang B; Zhang M; Hu B; Xue DQ; Shao KP; Zhang BL; Liu Y; Zhang E; Liu HM
    Eur J Med Chem; 2014 Oct; 86():368-80. PubMed ID: 25180925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel Pyrazolo[3,4-d]pyrimidines as Potential Cytotoxic Agents: Design, Synthesis, Molecular Docking and CDK2 Inhibition.
    Maher M; Kassab AE; Zaher AF; Mahmoud Z
    Anticancer Agents Med Chem; 2019; 19(11):1368-1381. PubMed ID: 31038080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of 2,4-diarylaminopyrimidine derivatives bearing dithiocarbamate moiety as novel FAK inhibitors with antitumor and anti-angiogenesis activities.
    Su Y; Li R; Ning X; Lin Z; Zhao X; Zhou J; Liu J; Jin Y; Yin Y
    Eur J Med Chem; 2019 Sep; 177():32-46. PubMed ID: 31129452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis and preliminary biological evaluation of 5,8-dihydropteridine-6,7-diones that induce apoptosis and suppress cell migration.
    Geng PF; Wang CC; Li ZH; Hu XN; Zhao TQ; Fu DJ; Zhao B; Yu B; Liu HM
    Eur J Med Chem; 2018 Jan; 143():1959-1967. PubMed ID: 29133051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and synthesis of isatin/triazole conjugates that induce apoptosis and inhibit migration of MGC-803 cells.
    Yu B; Wang SQ; Qi PP; Yang DX; Tang K; Liu HM
    Eur J Med Chem; 2016 Nov; 124():350-360. PubMed ID: 27597411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel pyrazole-5-carboxamide and pyrazole-pyrimidine derivatives: synthesis and anticancer activity.
    Shi JB; Tang WJ; Qi XB; Li R; Liu XH
    Eur J Med Chem; 2015 Jan; 90():889-96. PubMed ID: 25554922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, anticancer activity and effects on cell cycle profile and apoptosis of novel thieno[2,3-d]pyrimidine and thieno[3,2-e] triazolo[4,3-c]pyrimidine derivatives.
    Kandeel MM; Refaat HM; Kassab AE; Shahin IG; Abdelghany TM
    Eur J Med Chem; 2015 Jan; 90():620-32. PubMed ID: 25499930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis and biological evaluation of 1H-pyrazolo [3,4-d]pyrimidine derivatives as PAK1 inhibitors that trigger apoptosis, ER stress and anti-migration effect in MDA-MB-231 cells.
    Zhang J; Zou L; Tang P; Pan D; He Z; Yao D
    Eur J Med Chem; 2020 May; 194():112220. PubMed ID: 32222676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of N-phenyl-(2,4-dihydroxypyrimidine-5-sulfonamido) phenylurea-based thymidylate synthase (TS) inhibitor as a novel multi-effects antitumor drugs with minimal toxicity.
    Li XY; Zhang TJ; Kamara MO; Lu GQ; Xu HL; Wang DP; Meng FH
    Cell Death Dis; 2019 Jul; 10(7):532. PubMed ID: 31296849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.